Weeks 5-10 execution epitalon cycles and semax morning

What's happening at Week 5

The Phase 1 problem was architecture. Phase 2 is signal quality.

By age 40+, the pineal gland undergoes progressive calcification — calcium deposits accumulate in the tissue, physically reducing the gland's functional capacity. By age 60, endogenous melatonin production declines 50–80% compared to peak adolescent levels. DSIP nudged deep-sleep delta waves and helped melatonin land on receptors that were already getting some signal. Epitalon does something fundamentally different — it restores the upstream production of that signal. Epitalon is a synthetic analog of epithalamin, the natural pineal tetrapeptide. It acts at the genetic level, activating telomerase and modulating clock-gene transcription in the suprachiasmatic nucleus and pineal tissue. The downstream effect is that the gland starts producing more melatonin on its own — which is why practitioners describe Epitalon effects persisting for weeks after cycle completion, long after the peptide itself has cleared.

Semax is the morning-side mirror image. Phase 1 brought your nervous system back from sympathetic dominance via Selank — a GABAergic-mimetic that quieted noise. Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic ACTH(4-10) analog and melanocortin derivative. The substrate is explicit: melanocortin derivatives correct gene-expression patterns in the hippocampus following acute stress. Practically, that means Semax upregulates BDNF and NGF in cortical and hippocampal tissue, modulates serotonergic and dopaminergic tone, and produces a cognitive lift that is clean — alertness without sympathetic recruitment, learning capacity without dopaminergic crash. FDA-approved in Russia for cognitive impairment and stroke recovery. The 6–8 hour duration means a single morning dose carries you through the cortisol-curve danger zones — the 10am dip and the 3pm crash — without re-stimulating the cortisol axis that Phase 1 just spent four weeks resetting.

The architecture of Phase 2, then: Epitalon evenings, layered onto DSIP, restores the production of the molecules DSIP was helping reach the receptor. Semax mornings, replacing nothing in Phase 1, adds a cognitive ceiling lift that the cortisol-quiet brain can now actually use. Selank afternoons stays. DSIP nightly stays. You are not swapping compounds — you are stacking.

Phase 2 layered protocol — Weeks 5-10

Reconstitution and storage (substrate-cited): Epitalon lyophilized powder is stable at room temperature or refrigerated for 2+ years. Reconstituted solution: refrigerate, use within 28 days. Do not freeze reconstituted peptide. Subcutaneous administration is the only reliably-bioavailable route per the research base — oral degrades in digestion, sublingual and nasal formulations exist but lack the supporting evidence for the dosing schedules above.

Sequencing inside the day:

• Morning (within 30 min of waking): Semax 200–600 mcg intranasal. Take before the cortisol-awakening response peaks naturally — you're not blunting CAR, you're handing it cognitive substrate to work with.
• Afternoon (1–2 PM): Selank 200–400 mcg intranasal. Counters the post-lunch cortisol-curve dip. Holds the anxiolytic ceiling clean through the 3pm crash.
• Evening (30–60 min pre-bed): Epitalon SubQ + DSIP SubQ. Two separate injections, not blended in one vial — substrate is explicit that blended vials lose the ability to isolate effects and adjust independently. The synergy is the timing, not the mixture.

What you should feel — Week 5 through Week 10

• Week 5 (Days 28–35): Semax morning lift is immediate — within 60–90 minutes of the first dose. Cognitive flexibility on tasks that previously required coffee. Epitalon onset is quieter — the first 3–4 nights you may notice deeper sleep continuity than DSIP alone produced.
• Week 6 (Days 35–42): Epitalon 10-day cycle ends mid-week. Effects persist — substrate is clear that Epitalon benefits continue for weeks after the cycle completes because the pineal itself is now producing more endogenous melatonin. Don't restart the cycle.
• Week 7 (Days 42–49): Selank 10-day washout begins. You may notice the afternoon anxiolytic ceiling soften slightly — this is by design, not failure. Receptor reset, not effect fade.
• Week 8 (Days 49–56): Semax 10-day washout. Cognitive lift attenuates. Selank resumes. Watch HRV — should hold its Phase 1 floor even without active anxiolytic, which is the marker that the architecture is now self-sustaining.
• Week 9–10 (Days 56–70): Re-pull salivary cortisol-awakening response. This is the lab inflection point for the full protocol. DUTCH at Day 70 should show reorganized diurnal curve — not just CAR. Semax resumes Week 10.

What's NOT happening yet

• Telomere length is not measurably changing on standard lab panels. Epitalon's telomerase activation is a cellular effect; commercial telomere-length tests are noisy and not the right readout at 10 weeks. The salivary cortisol curve, melatonin nightly output (if you can measure 6-sulfatoxymelatonin), and subjective sleep architecture are the real Phase 2 markers.
• You should not run Epitalon continuously. The substrate is explicit — "if effects persist, continuous administration provides no additional benefit while introducing unnecessary exposure." Ten days on, 110+ days off. The next cycle is Month 4 or 5, not Week 11.
• Semax is not Modafinil. If you're chasing stimulant-shaped lift, you've miscalibrated. Semax raises the ceiling, not the floor. Subtle, durable, BDNF-mediated. Different mechanism, different felt experience.
• You are not re-pulling thyroid antibodies yet. Phase 2 isn't a thyroid protocol. If your baseline flagged Hashimoto's or autoimmune thyroid involvement, the Sleep/Cortisol Path is foundational — not the lever for TPO/TGA. That's a different Path entirely.
• Phase 1 compounds are not winding down. DSIP nightly continues. Selank afternoon continues (with its 30/10 cycle). Phase 2 is additive, not replacement. The four-compound stack runs together for the back half of the protocol.

Research describes this layering. Track the cortisol curve, the melatonin output, and the Week 8 HRV floor. Adjust.